If their cpn formulation doesn't work for mild lupus why should...

  1. 1,072 Posts.
    lightbulb Created with Sketch. 126
    If their cpn formulation doesn't work for mild lupus why should it work for major lupus ... I think I am sceptical of the trial producing a good result. Plus we are now seeing changes here and there it indicates to me that they have not had an orderly enrolment . Price and supplies have probably hampered the ideal design .

    I don't think they want it to complete before SC.

    I think SC will report first in July with analysis to follow . Just a guess.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
12.5¢
Change
0.000(0.00%)
Mkt cap ! $10.59M
Open High Low Value Volume
13.0¢ 13.5¢ 12.5¢ $15.62K 118.9K

Buyers (Bids)

No. Vol. Price($)
4 213400 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 57707 2
View Market Depth
Last trade - 14.46pm 20/06/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.